×
About 341 results

ALLMedicine™ Hyperglucagonemia Center

Research & Reviews  169 results

Glucagonostatic Potency of GLP-1 in Patients with Type 2 Diabetes, in Patients with Typ...
https://doi.org/10.2337/db20-0998
Diabetes Bagger JI, Grøndahl M et. al.

Mar 16th, 2021 - Hyperglucagonemia is a well-known contributor to diabetic hyperglycemia, and glucagon-like peptide-1 (GLP-1) suppresses glucagon secretion. Reduced inhibitory effects of glucose and GLP-1 on glucagon secretion may contribute to the hyperglucagonem...

Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hype...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881862
Diabetes Bozadjieva Kramer N, Lubaczeuski C et. al.

Nov 26th, 2020 - Elevation of glucagon levels and increase in α-cell mass are associated with states of hyperglycemia in diabetes. Our previous studies have highlighted the role of nutrient signaling via mTOR complex 1 (mTORC1) regulation that controls glucagon se...

A review of the Efficacy and Cardiovascular Safety of Amylin Analogues.
https://doi.org/10.2174/1574886315999201105153852
Current Drug Safety; Koshy RM, Fernandez CJ et. al.

Nov 6th, 2020 - A large proportion of persons with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) do not reach the glycosylated haemoglobin (HbA1c) target of < 7% (53 mmol/mol) with an increasing proportion of them being overweight or obese. ...

Pseudo-hyperglucagonemia was observed in pancreatectomized patients when measured by gl...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858105
Journal of Diabetes Investigation; Kobayashi M, Waki H et. al.

Jun 17th, 2020 - Glucagon is detected in plasma even after total pancreatectomy, and it is debated whether this glucagon is derived from the gastrointestinal tract. Here, we applied sandwich enzyme-linked immunosorbent assay (ELISA) and liquid chromatography-high-...

Effect of short-term intensive insulin therapy on α-cell function in patients with newl...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440309
Medicine Zheng HL, Xing Y et. al.

Apr 3rd, 2020 - The effect of intensive insulin therapy on hyperglucagonemia in newly diagnosed type 2 diabetes (T2DM), and its associations with β-cell function, has not been elucidated. This study assessed the effect of 12 weeks of intensive insulin therapy on ...

see more →

Clinicaltrials.gov  171 results

Glucagonostatic Potency of GLP-1 in Patients with Type 2 Diabetes, in Patients with Typ...
https://doi.org/10.2337/db20-0998
Diabetes Bagger JI, Grøndahl M et. al.

Mar 16th, 2021 - Hyperglucagonemia is a well-known contributor to diabetic hyperglycemia, and glucagon-like peptide-1 (GLP-1) suppresses glucagon secretion. Reduced inhibitory effects of glucose and GLP-1 on glucagon secretion may contribute to the hyperglucagonem...

Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hype...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881862
Diabetes Bozadjieva Kramer N, Lubaczeuski C et. al.

Nov 26th, 2020 - Elevation of glucagon levels and increase in α-cell mass are associated with states of hyperglycemia in diabetes. Our previous studies have highlighted the role of nutrient signaling via mTOR complex 1 (mTORC1) regulation that controls glucagon se...

A review of the Efficacy and Cardiovascular Safety of Amylin Analogues.
https://doi.org/10.2174/1574886315999201105153852
Current Drug Safety; Koshy RM, Fernandez CJ et. al.

Nov 6th, 2020 - A large proportion of persons with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) do not reach the glycosylated haemoglobin (HbA1c) target of < 7% (53 mmol/mol) with an increasing proportion of them being overweight or obese. ...

Pseudo-hyperglucagonemia was observed in pancreatectomized patients when measured by gl...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858105
Journal of Diabetes Investigation; Kobayashi M, Waki H et. al.

Jun 17th, 2020 - Glucagon is detected in plasma even after total pancreatectomy, and it is debated whether this glucagon is derived from the gastrointestinal tract. Here, we applied sandwich enzyme-linked immunosorbent assay (ELISA) and liquid chromatography-high-...

Effect of short-term intensive insulin therapy on α-cell function in patients with newl...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440309
Medicine Zheng HL, Xing Y et. al.

Apr 3rd, 2020 - The effect of intensive insulin therapy on hyperglucagonemia in newly diagnosed type 2 diabetes (T2DM), and its associations with β-cell function, has not been elucidated. This study assessed the effect of 12 weeks of intensive insulin therapy on ...

see more →

News  1 results

Multiple Metabolic Abnormalities Seen in Lupus
https://www.medpagetoday.com/rheumatology/lupus/64321

Apr 4th, 2017 - Action Points Note that this meal-tolerance study suggested that patients with mild or inactive lupus had greater indices of insulin resistance than healthy controls. Be aware that the small sample size precluded final adjustment for potential con...

see more →